Editor's Highlight: Prospective Analyses of Volatile Organic Compounds in Obstructive Sleep Apnea Patients

Area of Science:

• Environmental Health
• Pulmonology
• Analytical Chemistry

Background:

• Volatile organic compounds (VOCs) are toxic, and their profiles in obstructive sleep apnea (OSA) are not fully understood.
• Exhaled VOC patterns are altered in OSA patients, necessitating detailed characterization.

Purpose of the Study:

• To characterize exhaled VOCs in patients with obstructive sleep apnea (OSA).
• To investigate the relationship between VOC profiles and OSA severity, sleep parameters, and clinical factors.
• To assess the impact of continuous positive airway pressure (CPAP) treatment on VOC levels.

Main Methods:

• Prospective study of 32 OSA patients (apnea-hypopnea index [AHI] ≥ 15) and 33 controls using full polysomnography.
• Gas chromatography-mass spectrometry (GC-MS) identified and quantified exhaled VOCs, eliminating environmental influences.
• Nine severe OSA patients were evaluated before and after CPAP treatment.

Main Results:

• Elevated concentrations of aromatic hydrocarbons (toluene, ethylbenzene, p-xylene, phenylacetic acid) and saturated hydrocarbons (hexane, heptane, octane, nonane, decane) were found in severe OSA groups.
• Isoprene levels increased in all OSA groups, while acetone increased in the most severe OSA group.
• Ethylbenzene, p-xylene, phenylacetic acid, and nonane correlated with OSA severity (AHI, arousal index, duration of SpO2 ≤ 90%) and decreased after CPAP treatment.

Conclusions:

• Obstructive sleep apnea (OSA) is associated with increased levels of certain toxic volatile organic compounds (VOCs).
• The concentrations of specific VOCs correlate with OSA severity and duration of nocturnal hypoxia.
• Continuous positive airway pressure (CPAP) treatment may help ameliorate the production of these VOCs in OSA patients.